<DOC>
<DOCNO>
EP-0011739
</DOCNO>
<TEXT>
<DATE>
19800611
</DATE>
<IPC-CLASSIFICATIONS>
C12N-9/10 A61K-38/16 C07K-14/435 C07K-14/745 A61K-38/43 <main>C07G-7/00</main> A61L-2/00 A61K-35/50 A61K-38/00 A61K-35/48 A61K-35/16 
</IPC-CLASSIFICATIONS>
<TITLE>
process for obtaining blood coagulation factor xiii derived from human placenta.
</TITLE>
<APPLICANT>
green cross corpjp<sep>the green cross corporation<sep>the green cross corporation1-47, chuo-1-chomejoto-ku, osakajp<sep>the green cross corporation  <sep>
</APPLICANT>
<INVENTOR>
fukushima tunekazu<sep>funakoshi satoshi<sep>fukushima, tunekazu<sep>funakoshi, satoshi<sep>fukushima, tunekazu18-2, shioyadai-3-chometarumi-ku, kobejp<sep>funakoshi, satoshi16-5, aoyama-1-chomekatano-shijp<sep>fukushima, tunekazu<sep>funakoshi, satoshi<sep>fukushima, tunekazu18-2, shioyadai-3-chometarumi-ku, kobejp<sep>funakoshi, satoshi16-5, aoyama-1-chomekatano-shijp<sep>
</INVENTOR>
<ABSTRACT>
the invention relates to a process for concentrating  blood coagulation factor xiii (fibrin stabilizing factor) which  comprises removing a fraction precipitated at a ph of 6 to 9  in a concentration of 4 to 9% (w/v) of an alkylene oxide  polymer or copolymer having a molecular weight of 2,000 to  20,000 from a crude globulin fraction obtained from human  placenta by separating an albumin fraction therefrom, then  collecting the fraction precipitated in the concentration of 20  to 30% (w/v) of said polymer, and thereby easily obtaining  said blood coagulation factor xiii free from pyrogens in a  good yield.  
</ABSTRACT>
</TEXT>
</DOC>
